Mark Ashby
Medtronic (Ireland)(IE)
Publications by Year
Research Areas
Hematopoietic Stem Cell Transplantation, Platelet Disorders and Treatments, Central Venous Catheters and Hemodialysis, Blood groups and transfusion, Polyomavirus and related diseases
Most-Cited Works
- → Cardiac Dysfunction in the Trastuzumab Clinical Trials Experience(2002)1,488 cited
- → Omalizumab in patients with symptomatic chronic idiopathic/spontaneous urticaria despite standard combination therapy(2013)553 cited
- → Clinical Outcomes Associated with Bevacizumab-Containing Treatment of Metastatic Colorectal Cancer: The BRiTE Observational Cohort Study(2009)307 cited
- → Recombinant Human Thrombopoietin Attenuates Carboplatin-Induced Severe Thrombocytopenia and the Need for Platelet Transfusions in Patients with Gynecologic Cancer(2000)193 cited
- → Omalizumab, a recombinant humanized anti-IgE antibody, reduces asthma-related emergency room visits and hospitalizations in patients with allergic asthma(2003)188 cited
- → Clinical Outcomes in Elderly Patients with Metastatic Colorectal Cancer Receiving Bevacizumab and Chemotherapy: Results from the BRiTE Observational Cohort Study(2010)125 cited
- → A Multicenter Study of Platelet Recovery and Utilization in Patients After Myeloablative Therapy and Hematopoietic Stem Cell Transplantation(1998)115 cited
- → Military Applications of Artificial Intelligence: Ethical Concerns in an Uncertain World(2020)88 cited
- → A phase I trial of recombinant human thrombopoietin in patients with delayed platelet recovery after hematopoietic stem cell transplantation(2000)86 cited